Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1
Overview
Medical Informatics
Authors
Affiliations
The acetylglucosaminyltransferase-like protein LARGE1 is an enzyme that is responsible for the final steps of the post-translational modifications of dystroglycan (DG), a membrane receptor that links the cytoskeleton with the extracellular matrix in the skeletal muscle and in a variety of other tissues. LARGE1 acts by adding the repeating disaccharide unit [-3Xyl-α1,3GlcAβ1-] to the extracellular portion of the DG complex (α-DG); defects in the gene result in an aberrant glycosylation of α-DG and consequent impairment of its binding to laminin, eventually affecting the connection between the cell and the extracellular environment. In the skeletal muscle, this leads to degeneration of the muscular tissue and muscular dystrophy. So far, a few missense mutations have been identified within the LARGE1 protein and linked to congenital muscular dystrophy, and because no structural information is available on this enzyme, our understanding of the molecular mechanisms underlying these pathologies is still very limited. Here, we generated a 3D model structure of the two catalytic domains of LARGE1, combining different molecular modeling approaches. Furthermore, by using molecular dynamics simulations, we analyzed the effect on the structure and stability of the first catalytic domain of the pathological missense mutation S331F that gives rise to a severe form of muscle-eye-brain disease.
Metabolic Engineering of Glycofusion Bispecific Antibodies for α-Dystroglycanopathies.
Zhong X, Yan G, Chaturvedi A, Li X, Gao Y, Girgenrath M Antibodies (Basel). 2024; 13(4).
PMID: 39449325 PMC: 11503271. DOI: 10.3390/antib13040083.
Hassan B, Milicaj J, Ramirez-Mondragon C, Sham Y, Taylor E J Chem Inf Model. 2021; 62(2):324-339.
PMID: 34967618 PMC: 8864558. DOI: 10.1021/acs.jcim.1c00868.
Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.
Shelton G, Minor K, Guo L, Friedenberg S, Cullen J, Hord J Neuromuscul Disord. 2021; 31(11):1169-1178.
PMID: 34654610 PMC: 8963908. DOI: 10.1016/j.nmd.2021.07.016.
Bigotti M, Brancaccio A Open Biol. 2021; 11(9):210104.
PMID: 34582712 PMC: 8478517. DOI: 10.1098/rsob.210104.
Ramirez-Mondragon C, Nguyen M, Milicaj J, Hassan B, Tucci F, Muthyala R Int J Mol Sci. 2021; 22(9).
PMID: 33924837 PMC: 8124905. DOI: 10.3390/ijms22094619.